Jeffrey Dayno

President and Chief Executive OfficeratHarmony Biosciences Holdings· In proxies 2021–2025

Pay in FY2025+11% from the year before · Harmony Biosciences Holdings stock +8.7% the same year

Jeffrey Dayno was paid $7.9M in FY2025 (Dec), up 11%. Harmony Biosciences Holdings stock rose 8.7% that year.

Pay$100 in the stock at the end of FY22 → $68

Pay is from the Summary Compensation Table of each Harmony Biosciences Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

Harmony Biosciences HoldingsPublic company · 5 yr
- President and Chief Executive Officer2021 – Present · 5 yrStock in role +6%

Roles come from the proxy statements of each company.

Activity

Pay
Harmony Biosciences Holdings CEO pay rose 11% to $7.9M. The stock rose 9% in FY2025 (Dec).
DEF 14AApr 3, 2026
Pay
Harmony Biosciences Holdings CEO pay rose 61% to $7.1M. The stock rose 7% in FY2024 (Dec).
DEF 14AApr 4, 2025

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?